Livzon Pharmaceutical Group Inc (000513) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.040x

Based on the latest financial reports, Livzon Pharmaceutical Group Inc (000513) has a cash flow conversion efficiency ratio of 0.040x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥625.70 Million ≈ $91.56 Million USD) by net assets (CN¥15.79 Billion ≈ $2.31 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000513 equity to assets ratio to measure how much of total assets are equity-financed.

Livzon Pharmaceutical Group Inc - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Livzon Pharmaceutical Group Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 000513 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Livzon Pharmaceutical Group Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Livzon Pharmaceutical Group Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Huaming Power Equipment Co Ltd SHE:002270	0.013x
Worthington Industries Inc NYSE:WOR	0.053x
Bird Construction Inc. TO:BDT	0.014x
Transmissora Aliança de Energia Elétrica S.A SA:TAEE11	0.086x
Shanghai V-Test Semiconductor Tech Co. Ltd. A SHG:688372	N/A
Wuxi Taclink Optoelectronics Technology Co. Ltd. A SHG:688205	N/A
VGP NV BR:VGP	-0.006x
BKV Corporation NYSE:BKV	0.034x

Annual Cash Flow Conversion Efficiency for Livzon Pharmaceutical Group Inc (1998–2025)

The table below shows the annual cash flow conversion efficiency of Livzon Pharmaceutical Group Inc from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Livzon Pharmaceutical Group Inc stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥15.79 Billion ≈ $2.31 Billion	CN¥3.18 Billion ≈ $465.18 Million	0.201x	+0.75%
2024-12-31	CN¥14.91 Billion ≈ $2.18 Billion	CN¥2.98 Billion ≈ $435.90 Million	0.200x	-9.17%
2023-12-31	CN¥14.77 Billion ≈ $2.16 Billion	CN¥3.25 Billion ≈ $475.42 Million	0.220x	+18.52%
2022-12-31	CN¥14.94 Billion ≈ $2.19 Billion	CN¥2.77 Billion ≈ $405.73 Million	0.186x	+39.65%
2021-12-31	CN¥14.31 Billion ≈ $2.09 Billion	CN¥1.90 Billion ≈ $278.37 Million	0.133x	-16.09%
2020-12-31	CN¥13.64 Billion ≈ $2.00 Billion	CN¥2.16 Billion ≈ $316.19 Million	0.158x	+10.04%
2019-12-31	CN¥12.28 Billion ≈ $1.80 Billion	CN¥1.77 Billion ≈ $258.59 Million	0.144x	+33.44%
2018-12-31	CN¥11.75 Billion ≈ $1.72 Billion	CN¥1.27 Billion ≈ $185.49 Million	0.108x	-7.90%
2017-12-31	CN¥11.23 Billion ≈ $1.64 Billion	CN¥1.32 Billion ≈ $192.55 Million	0.117x	-34.93%
2016-12-31	CN¥7.11 Billion ≈ $1.04 Billion	CN¥1.28 Billion ≈ $187.19 Million	0.180x	-6.67%
2015-12-31	CN¥4.81 Billion ≈ $703.84 Million	CN¥927.79 Million ≈ $135.76 Million	0.193x	+9.77%
2014-12-31	CN¥4.08 Billion ≈ $597.39 Million	CN¥717.39 Million ≈ $104.98 Million	0.176x	+43.96%
2013-12-31	CN¥3.60 Billion ≈ $527.45 Million	CN¥439.99 Million ≈ $64.38 Million	0.122x	-34.65%
2012-12-31	CN¥3.18 Billion ≈ $465.35 Million	CN¥593.96 Million ≈ $86.92 Million	0.187x	-20.57%
2011-12-31	CN¥3.01 Billion ≈ $440.69 Million	CN¥708.20 Million ≈ $103.63 Million	0.235x	-2.00%
2010-12-31	CN¥2.64 Billion ≈ $386.19 Million	CN¥633.30 Million ≈ $92.67 Million	0.240x	+7.91%
2009-12-31	CN¥2.23 Billion ≈ $325.65 Million	CN¥494.88 Million ≈ $72.42 Million	0.222x	+18.18%
2008-12-31	CN¥1.83 Billion ≈ $268.45 Million	CN¥345.18 Million ≈ $50.51 Million	0.188x	+50.71%
2007-12-31	CN¥1.99 Billion ≈ $291.33 Million	CN¥248.55 Million ≈ $36.37 Million	0.125x	-20.69%
2006-12-31	CN¥1.44 Billion ≈ $210.51 Million	CN¥226.46 Million ≈ $33.14 Million	0.157x	+21.03%
2005-12-31	CN¥1.24 Billion ≈ $181.22 Million	CN¥161.07 Million ≈ $23.57 Million	0.130x	-16.00%
2004-12-31	CN¥1.17 Billion ≈ $171.49 Million	CN¥181.46 Million ≈ $26.55 Million	0.155x	-39.38%
2003-12-31	CN¥1.17 Billion ≈ $171.87 Million	CN¥300.01 Million ≈ $43.90 Million	0.255x	+35.12%
2002-12-31	CN¥1.13 Billion ≈ $165.38 Million	CN¥213.65 Million ≈ $31.26 Million	0.189x	+25.81%
2001-12-31	CN¥1.03 Billion ≈ $151.09 Million	CN¥155.15 Million ≈ $22.70 Million	0.150x	+277.27%
2000-12-31	CN¥967.05 Million ≈ $141.51 Million	CN¥38.52 Million ≈ $5.64 Million	0.040x	-84.25%
1999-12-31	CN¥973.90 Million ≈ $142.51 Million	CN¥246.23 Million ≈ $36.03 Million	0.253x	+1449.54%
1998-12-31	CN¥972.07 Million ≈ $142.24 Million	CN¥-18.21 Million ≈ $-2.66 Million	-0.019x	--

About Livzon Pharmaceutical Group Inc

SHE:000513 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.68 Billion

CN¥18.31 Billion CNY

Market Cap Rank

#5174 Global

#888 in China

Share Price

CN¥31.13

Change (1 day)

+0.39%

52-Week Range

CN¥28.43 - CN¥42.41

All Time High

CN¥1418.81